Latest News Archive
Please select Category, Year, and then Month to display items
23 June 2023
|
Story Naledi Filita
|
Photo Supplied
Naledi Filita is an nGAP Lecturer in the Department of Languages in Education.
The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.
Naledi Filita, nGAP Lecturer in the Department of Languages in Education, shares her UFS journey:
Q: Year of graduation from the UFS:
A: 2016, 2018, and 2021.
Q: Qualification obtained from the UFS:
A: Bachelor of Education, Postgraduate Diploma in Education (Curriculum Studies), and Master of Education (Curriculum Studies).
Q: Date of joining the UFS as a staff member:
A: 2021.
Q: Initial job title and current job title:
A: Lecturer.
Q: How did the UFS prepare you for the professional world?
A: I started my career as a teacher in 2015 and was later appointed to my current job. The UFS has equipped me with the knowledge and skills that enabled me to be competent in my field in various contexts. My journey as a UFS student equipped me with crucial skills, such as critical thinking, communication, teamwork, and organisational skills.
Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?
A: It has been a wonderful experience so far. I was once a student teacher at this university. Due to my experiences, being able to instil knowledge and skills in student teachers is something that I am passionate about. I am grateful for the developmental opportunities and support that I receive as a young researcher.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”